Literature DB >> 34180045

British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.

Sally B Killick1, Wendy Ingram2, Dominic Culligan3, Helen Enright4, Jonathan Kell2, Elspeth M Payne5, Pramila Krishnamurthy6, Austin Kulasekararaj6, Manoj Raghavan7, Simon J Stanworth8, Simone Green9, Ghulam Mufti6, Lynn Quek6, Catherine Cargo10, Gail L Jones11, Juliet Mills12, Alex Sternberg13, Daniel H Wiseman14, David Bowen10.   

Abstract

Entities:  

Keywords:  MDS; guideline; management; myelodysplastic syndromes

Mesh：

Substances：

Year:  2021        PMID： 34180045     DOI： 10.1111/bjh.17612

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  BMT for Myelodysplastic Syndrome: When and Where and How.

Authors:  Akriti G Jain; Hany Elmariah
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

Review 2.  Myelodysplastic Syndromes and Metabolism.

Authors:  Ekaterina Balaian; Manja Wobus; Martin Bornhäuser; Triantafyllos Chavakis; Katja Sockel
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

3.  Azacitidine-Induced Pneumonitis in a Patient With Acute Myeloid Leukemia and Hyperleukocytosis.

Authors:  Rafaella Litvin; Mona Dasgupta; Mohamed Saad Eldin; Mihir Shah; Sherene Fakhran
Journal:  Cureus       Date:  2022-07-11

4.  Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia.

Authors:  Antonio Gidaro; Alessandro Palmerio Delitala; Alessandra Berzuini; Mark J Soloski; Pietro Manca; Dante Castro; Emanuele Salvi; Roberto Manetti; Giorgio Lambertenghi Deliliers; Roberto Castelli
Journal:  J Clin Med       Date:  2022-08-14       Impact factor: 4.964

5.  Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire: The MINDSET study.

Authors:  Johanne Rozema; Eric van Roon; Lars Vogelzang; Robby Kibbelaar; Nic Veeger; Arjan van de Loosdrecht; Mels Hoogendoorn
Journal:  Eur J Haematol       Date:  2022-07-06       Impact factor: 3.674
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.